Burning Rock Biotech

(NASDAQ) BNR

Current Price$16.15

Market Cap$146.71M

Since IPO (2020)-93%

5 Year-95%

1 Year+462%

1 Month+2%

Burning Rock Biotech Financials at a Glance

Market Cap

$146.71M

Revenue (TTM)

$537.82M

Net Income (TTM)

$55.13M

EPS (TTM)

$-0.72

P/E Ratio

-22.51

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$16.15

Volume

759

Open

$16.12

Price

$16.15

Volume

759

Open

$16.12

Previous Close

$16.15

Daily Range

$15.42 - $16.49

52-Week Range

$2.18 - $41.72

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$16.15

Volume

759

Open

$16.12

Previous Close

$16.15

Daily Range

$15.42 - $16.49

52-Week Range

$2.18 - $41.72

BNR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Burning Rock Biotech

Industry

Biotechnology

Sector

Health Care

Employees

674

CEO

Yu Sheng Han, MBA

Website

www.brbiotech.com

Headquarters

Guangzhou, 510005, CN

BNR Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-10%

Net Income Margin

-10%

Return on Equity

-10%

Return on Capital

-10%

Return on Assets

-7%

Earnings Yield

-4.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$146.71M

Shares Outstanding

9.03M

Volume

759

Avg. Volume

26.68K

Financials (TTM)

Gross Profit

$391.94M

Operating Income

$53.35M

EBITDA

$43.05M

Operating Cash Flow

$92.26M

Capital Expenditure

$5.98M

Free Cash Flow

$98.24M

Cash & ST Invst.

$481.39M

Total Debt

$43.15M

Burning Rock Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$124.57M

-1.2%

Gross Profit

$97.21M

+8.7%

Gross Margin

78.03%

N/A

Market Cap

$146.71M

N/A

Market Cap/Employee

$217.68K

N/A

Employees

674

N/A

Net Income

$15.17M

+81.3%

EBITDA

$9.06M

+80.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$438.25M

-6.3%

Accounts Receivable

$182.03M

+4.9%

Inventory

$57.01M

+6.0%

Long Term Debt

$26.17M

-5.7%

Short Term Debt

$16.97M

-30.9%

Return on Assets

-6.72%

N/A

Return on Invested Capital

-9.53%

N/A

Free Cash Flow

$16.39M

+154.1%

Operating Cash Flow

$16.39M

+154.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EKSOEkso Bionics Holdings, Inc.

EKSOEkso Bionics Holdings, Inc.$11.44+2.05%

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.52-1.18%

PMNProMIS Neurosciences, Inc.

PMNProMIS Neurosciences, Inc.$11.15+2.76%

AMSAmerican Shared Hospital Services

AMSAmerican Shared Hospital Services$1.34+0.75%

ADVBAdvanced Biomed Inc. Common Stock

ADVBAdvanced Biomed Inc. Common Stock$5.30+0.00%

ALURAllurion Technologies Inc.

ALURAllurion Technologies Inc.$0.74+8.82%

CODXCo-Diagnostics, Inc.

CODXCo-Diagnostics, Inc.$1.53-6.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$208.99-0.02%

INTCIntel

INTCIntel$94.75+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

NOKNokia

NOKNokia$12.46+0.10%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.08-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.93-0.02%

AMDAdvanced Micro Devices

AMDAdvanced Micro Devices$336.38+0.04%

Questions About BNR

What is the current price of Burning Rock Biotech?

Burning Rock Biotech is trading at $16.15 per share.

What is the 52-week range for Burning Rock Biotech?

Over the past 52 weeks, Burning Rock Biotech has traded between $2.18 and $41.72.

How much debt does Burning Rock Biotech have?

As of the most recent reporting period, Burning Rock Biotech reported total debt of $6.17M.

How much cash does Burning Rock Biotech have on hand?

Burning Rock Biotech reported $68.84M in cash and cash equivalents in its most recent financial results.

What is Burning Rock Biotech’s dividend yield?

Burning Rock Biotech does not currently have a dividend yield.

Burning Rock Biotech

Burning Rock Biotech Financials at a Glance

BNR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Burning Rock Biotech

BNR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Burning Rock Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BNR

What is the current price of Burning Rock Biotech?

What is the 52-week range for Burning Rock Biotech?

How much debt does Burning Rock Biotech have?

How much cash does Burning Rock Biotech have on hand?

What is Burning Rock Biotech’s dividend yield?

Premium Investing Services